Lionco Pharmaceutical Group Co.,Ltd. (SHA:603669)

China flag China · Delayed Price · Currency is CNY
4.610
-0.050 (-1.07%)
Mar 11, 2026, 2:14 PM CST
-3.35%
Market Cap 3.28B
Revenue (ttm) 430.61M
Net Income (ttm) -118.38M
Shares Out 703.54M
EPS (ttm) -0.16
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,780,160
Average Volume 8,182,038
Open 4.660
Previous Close 4.660
Day's Range 4.590 - 4.670
52-Week Range 3.450 - 7.050
Beta 0.37
RSI 52.39
Earnings Date Apr 25, 2026

About SHA:603669

Lionco Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products and medical services in China. It offers chemical and prescription drugs for nutrition, antimicrobial, antiviral, digestive, cardiovascular, cerebrovascular, detoxification, anti-tumor, and other applications. The company was founded in 2003 and is based in Shannan, China. [Read more]

Sector Healthcare
Founded 2003
Employees 436
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603669
Full Company Profile

Financial Performance

In 2024, SHA:603669's revenue was 379.78 million, an increase of 92.95% compared to the previous year's 196.83 million. Losses were -130.76 million, -13.68% less than in 2023.

Financial Statements

News

There is no news available yet.